Glenmark Pharmaceuticals consolidated net profit rises 23.49% in the March 2017 quarter

Sales rise 10.23% to Rs 2424.41 crore

Net profit of Glenmark Pharmaceuticals rose 23.49% to Rs 183.76 crore in the quarter ended March 2017 as against Rs 148.80 crore during the previous quarter ended March 2016. Sales rose 10.23% to Rs 2424.41 crore in the quarter ended March 2017 as against Rs 2199.45 crore during the previous quarter ended March 2016.

For the full year,net profit rose 49.22% to Rs 1108.75 crore in the year ended March 2017 as against Rs 743.05 crore during the previous year ended March 2016. Sales rose 20.28% to Rs 8970.09 crore in the year ended March 2017 as against Rs 7457.92 crore during the previous year ended March 2016.

 

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales2424.412199.45 10 8970.097457.92 20 OPM %18.3113.80 -22.7119.27 - PBDT322.89267.65 21 1836.751278.27 44 PBT253.98209.24 21 1572.381043.98 51 NP183.76148.80 23 1108.75743.05 49

Powered by Capital Market - Live News